Development of an innovative therapy for ANCA- associated vasculitis (AAV)

Research unit

INNOSUISSE

Project number

46411.1 IP-LS

Project title

Development of an innovative therapy for ANCA- associated vasculitis (AAV)

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-	-

Category	Text
Short description (German)	Development of an innovative therapy for ANCA- associated vasculitis (AAV)
Short description (English)	Development of an innovative therapy for ANCA- associated vasculitis (AAV)
Abstract (German)	AAV is a life-threatening autoimmune disease with no effective available treatment. 60% of patients are refractory to therapy or relapse within a year. This project aims to address this unmet medical need substantially advancing treatment by developing novel compounds targeting disease pathogenesis.